0000000000486002

AUTHOR

Philipp Stenzel

showing 2 related works from this author

Multimodal Deep Learning for Prognosis Prediction in Renal Cancer

2021

BackgroundClear-cell renal cell carcinoma (ccRCC) is common and associated with substantial mortality. TNM stage and histopathological grading have been the sole determinants of a patient’s prognosis for decades and there are few prognostic biomarkers used in clinical routine. Management of ccRCC involves multiple disciplines such as urology, radiology, oncology, and pathology and each of these specialties generates highly complex medical data. Here, artificial intelligence (AI) could prove extremely powerful to extract meaningful information to benefit patients.ObjectiveIn the study, we developed and evaluated a multimodal deep learning model (MMDLM) for prognosis prediction in ccRCC.Desig…

OncologyCancer ResearchPrognosis predictionmedicine.medical_specialtyrenal cancerDiseaseRenal cell carcinomaInternal medicinemedicineStage (cooking)Exome sequencingRC254-282Original Researchbusiness.industryDeep learningCancerdeep learningNeoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseartificial intelligenceradiologyOncologyCohortpathologyArtificial intelligenceprognosis predictionbusinessFrontiers in Oncology
researchProduct

Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.

2020

Abstract Background Muscle-invasive bladder cancer (MIBC) is the second most common genitourinary malignancy, and is associated with high morbidity and mortality. Recently, molecular subtypes of MIBC have been identified, which have important clinical implications. Objective In the current study, we tried to predict the molecular subtype of MIBC samples from conventional histomorphology alone using deep learning. Design, setting, and participants Two cohorts of patients with MIBC were used: (1) The Cancer Genome Atlas Urothelial Bladder Carcinoma dataset including 407 patients and (2) our own cohort including 16 patients with treatment-naive, primary resected MIBC. This resulted in a total …

medicine.medical_specialtyUrology030232 urology & nephrologyH&E stainDiseaseMalignancy03 medical and health sciences0302 clinical medicineDeep LearningCarcinomamedicineHumansNeoplasm InvasivenessBladder cancerReceiver operating characteristicbusiness.industryDeep learningmedicine.diseaseMolecular Diagnostic TechniquesUrinary Bladder Neoplasms030220 oncology & carcinogenesisHistopathologyArtificial intelligenceRadiologybusinessForecastingEuropean urology
researchProduct